Loading...

PE anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
a-30-F11_PE_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE
  • a-30-F11_PE_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE
  • b-30-F11_PE_CD45_Antibody_2_041922
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).

    Data was acquired on the Moxi Flow, exported, and processed using FlowJo software.
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
103105 50 µg 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103106 200 µg 69€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  2. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  3. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  4. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  5. Vercauteren Drubbel A, et al. 2021. Cell Stem Cell. . PubMed
  6. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  7. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  8. Hepler C et al. 2017. eLife. 6 pii: e27669. PubMed
  9. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  10. Khorooshi R, et al. 2020. Acta Neuropathol Commun. 8:02. PubMed
  11. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  12. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  13. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  14. d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
  15. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  16. Sun D, et al. 2021. Cell Stem Cell. . PubMed
  17. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  18. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  19. Hagan N, et al. 2020. Cell Death Dis. 1.086111111. PubMed
  20. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  21. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  22. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  23. Chen J, et al. 2021. Sci Adv. 7:. PubMed
  24. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  25. Maimets M, et al. 2016. Stem Cell Reports. 6:150-162. PubMed
  26. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  27. Cieslik KA, et al. 2018. J Gerontol A Biol Sci Med Sci. 73:1167. PubMed
  28. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  29. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  30. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  31. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  32. Catrina AM, et al. 2021. Rom J Morphol Embryol. 62:109. PubMed
  33. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  34. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  35. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  36. Ogawa M, et al. 2019. J Biol Methods. 5:e102. PubMed
  37. Shmeleva EV, et al. 2019. Front Immunol. 10:1780. PubMed
  38. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  39. Wang Y, et al. 2021. Nat Commun. 12:2343. PubMed
  40. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  41. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  42. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  43. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  44. Aoki H, et al. 2009. Development. 136:2511. PubMed
  45. Guha S, et al. 2014. Brain Behav Immun. 11:123. PubMed
  46. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  47. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  48. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  49. Serrano Martinez P, et al. 2022. iScience. 25:105047. PubMed
  50. Ogawa-Wong A, et al. 2022. Metabolites. 12:. PubMed
  51. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  52. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  53. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  54. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  55. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  56. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  57. An J, et al. 2022. iScience. 25:103570. PubMed
  58. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  59. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  60. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  61. Fontana D, et al. 2020. Hemasphere. e497:4. PubMed
  62. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  63. Green DP, et al. 2019. Neuron. 101:412. PubMed
  64. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  65. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  66. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  67. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  68. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  69. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  70. Chang CS, et al. 2022. iScience. 25:103738. PubMed
  71. Sinha VC, et al. 2021. Nat Commun. 12:5024. PubMed
  72. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  73. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  74. Slezak AJ, et al. 2022. ACS Cent Sci. 8:1435. PubMed
  75. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  76. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  77. Yang Z, et al. 2020. Sci Rep. 17757:10. PubMed
  78. Socodato R, et al. 2020. Sci Signal. 13: . PubMed
  79. Sardella C, et al. 2018. J Invest Dermatol. 138:500. PubMed
  80. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  81. Oliver J, et al. 2009. J Am Soc Nephrol. 2.440972222. PubMed
  82. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  83. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  84. Ebrahimi-Nik H, et al. 2021. Nat Commun. 12:6423. PubMed
  85. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  86. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  87. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  88. Ito T, et al. 2021. Commun Biol. 4:694. PubMed
  89. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  90. Barker KA, et al. 2021. Journal of Clinical Investigation. 131(11):. PubMed
  91. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  92. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  93. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  94. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  95. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  96. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  97. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  98. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  99. Wang QA et al. 2018. Cell metabolism. 28(2):282-288 . PubMed
  100. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  101. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  102. Douam F, et al. 2017. Mbio. 10.1128/mBio.00819-17. PubMed
  103. Meng X, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  104. Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed
  105. Kitajima Y, et al. 2022. Cells. 11:. PubMed
  106. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  107. Wijewarnasuriya D, et al. 2020. Cancer Immunol Res. 0.841666667. PubMed
  108. Bota-Rabassedas N, et al. 2021. Cell Reports. 35(3):109009. PubMed
  109. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  110. McCallion A, et al. 2022. Front Immunol. 13:961599. PubMed
  111. Matsumoto A, et al. 2021. iScience. 24:102839. PubMed
  112. Lee-Chang C, et al. 2021. J Exp Med. 218:. PubMed
  113. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  114. Senthil K, et al. 2021. Invest Ophthalmol Vis Sci. 62:38. PubMed
  115. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  116. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  117. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  118. Dholakia J, et al. 2022. Gynecol Oncol. 164:170. PubMed
  119. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  120. Kronborg Hansen AK, et al. 2022. Int J Mol Sci. 23:. PubMed
  121. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  122. Liu X, et al. 2021. Int J Med Sci. 18:3125. PubMed
  123. Song E, et al. 2020. Nature. 577:689. PubMed
  124. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  125. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  126. Milon B, et al. 2021. Cell Rep. 36:109758. PubMed
  127. Dieu RS, et al. 2021. Front Neurosci. 15:685645. PubMed
  128. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  129. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  130. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  131. Liu B, et al. 2013. Development. 140:780. PubMed
  132. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  133. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
  134. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  135. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  136. Sanz-Ros J, et al. 2022. Sci Adv. 8:eabq2226. PubMed
  137. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  138. Korin B, et al. 2020. Sleep. :43. PubMed
  139. An X, et al. 2020. Thyroid. . PubMed
  140. Xu L, et al. 2019. Haematologica. 10.3324/haematol.2018.207258. PubMed
  141. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  142. Bollinger JL, et al. 2020. Neuropsychopharmacology. 45:1766. PubMed
  143. Yue F, et al. 2022. Cell Rep. 38:110267. PubMed
  144. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  145. Nakao M, et al. 2021. Sci Rep. 11:18384. PubMed
  146. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  147. Orhon I, et al. 2021. Autophagy. :1. PubMed
  148. Szõke D, et al. 2021. Nat Commun. 12:3460. PubMed
  149. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  150. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  151. Gawish R, et al. 2022. Elife. 11:. PubMed
  152. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  153. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  154. Singh K, et al. 2021. Front Immunol. 640837:12. PubMed
  155. Wen G, et al. 2018. J Am Heart Assoc. 7:e008187. PubMed
  156. Stone S et al. 2018. Glia. 66(7):1331-1345 . PubMed
  157. Lehmann M, et al. 2020. Cell Signal. 70:109588. PubMed
  158. Cugurra A, et al. 2021. Science. 373:. PubMed
  159. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  160. Lupan AM, et al. 2021. Aging (Albany NY). 13:15875. PubMed
  161. Li J, et al. 2021. eLife. 10:00. PubMed
  162. Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed
  163. Engelmann R, et al. 2017. J Negat Results Biomed. 16:05. PubMed
  164. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  165. Lehmann ML, et al. 2018. Sci Rep. 8:11240. PubMed
RRID
AB_312970 (BioLegend Cat. No. 103105)
AB_312971 (BioLegend Cat. No. 103106)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account